Sanger Sequencing Market is anticipated to grow up to USD 13.4 Billion by 2032 | Thermo Fisher Scientific Inc, Source BioScience, GenScript, LGC Limited

The global Sanger Sequencing Market was valued at USD 1.9 Billion in 2022 and it is anticipated to grow up to USD 13.4 Billion by 2032, at a CAGR of 21.4% during the forecast period.

To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS10514

The Sanger technique of DNA sequencing relies on the random incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication and uses electrophoresis. However, for smaller-scale initiatives and for validating the outcomes of deep sequencing, the sanger approach is still widely used. It can still create DNA sequence reads of more than 500 nucleotides and maintain accuracy levels around 99.99 percent, giving it an edge over short-read sequencing methods (like Illumina).

Market Trends and Drivers:

The market for Sanger's sequencing services is expanding due to technological developments in sequencing methods, benefits of Sanger's sequencing, and an increase in genome mapping initiatives. Additionally, sequencing applications and R&D expenditure boost have added to the market's expansion.

Read more about Sanger Sequencing Market here: https://www.globalinsightservices.com/reports/sanger-sequencing-market/

Research and development (R&D) activities

The increased attention that vendors are paying to developing economies like China, India, and Southeast Asia is anticipated to promote market expansion. The market is expected to experience significant growth in the near future as a result of rising R&D spending and a boom in sanger sequencing applications.

Rise in genetic illness

The expanding use of genetic testing on vertebrates and plants, other factors influencing the market's growth include the rising prevalence and familiarity of genetic illnesses and tailored medicine. During the forecast period of 2022 to 2029, a few factors have the potential to propel market expansion.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10514

Global Sanger Sequencing Market Segmentation:

By Sequencing:
• Shotgun Sequencing
• Targeted Gene Sequencing
• Others

By Application:
• Diagnostics
• Biomarkers
• Cancer
• Reproductive Health
• Personalized Medicine
• Forensics
• Others

By End-user:
• Academic
• Government Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Hospitals
• Clinics

Major Players in the Global Sanger Sequencing Market:

The key players in the Sanger Sequencing Market Thermo Fisher Scientific Inc (U.S.), Source BioScience (U.K.), GenScript (U.S.), LGC Limited (U.K.), CeMIA (U.S.),, Quintara Biosciences (U.S.), GenHunter Corporation (U.S.), GENEWIZ (U.S.), , Nucleics (U.K.), SciGenom Labs Pvt. Ltd (India), Microsynth AG (Switzerland), Eurofins Scientific (Luxembourg), LGC Limited (U.K.), among others.

For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS10514

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.